In the era of drug-eluting stents, large-scale randomized trials and all-comer registries have
shown excellent clinical results. However, even the latest-generation drug-eluting stent has …

Abstract This Consensus Document is the first of two reports summarizing the views of an
expert panel organized by the European Association of Percutaneous Cardiovascular …

Although clinical outcomes after percutaneous coronary intervention (PCI) are improving,
the long-term risk for target vessel failure remains concerning. Although the application of …

Background No medium-term data are available on the random comparison between
everolimus-eluting bioresorbable vascular scaffolds and everolimus-eluting metallic stents …

Objectives: This study sought to determine the mechanistic effects of a novel balloon-based
lithoplasty system on heavily calcified coronary lesions and subsequent stent placement …

Objectives The aim of this study was to evaluate various stent expansion indexes to
determine the best predictor of clinical outcomes. Background Numerous intravascular …

Cardiovascular diseases are the first cause of mortality around the globe. One of the
promising treatment procedures is regenerating or repairing the heart tissues. Regarding …

Bioresorbable scaffolds (BRS) were developed to overcome the drawbacks of current
metallic drug-eluting stents (DES), such as late in-stent restenosis and caging of the vessel …

Local hemodynamic forces are well-known to modulate atherosclerotic evolution, which
remains one of the largest cause of death worldwide. Percutaneous coronary interventions …

Background The comparative efficacy of percutaneous techniques for the preparation of
calcified lesions before stenting remains poorly studied. Objectives This study sought to …